BACKGROUND: The aim was to ascertain the prognostic value of mid-regional pro-
adrenomedullin (MR-proADM), measured within 24 hours from the onset of septic shock …

Purpose: Midregional-proAdrenomedullin (MR-proADM) as a biomarker in the context of
cardiopulmonary bypass is a relevant marker for heart failure therapy and can predict …

Most sepsis will develop into multi organ failure (MOF). To assess manifestation of MOF,
SOFA score that includes several laboratory parameters for each organ is used. However …

Background The use of novel sepsis biomarkers has increased in recent years. However,
their prognostic value with respect to illness severity has not been explored. In this work, we …

Aortic stenosis (AS) is characterised both by progressive valve narrowing and the
remodelling response of the left ventricle (LV) that occurs secondary to an increased …

BACKGROUND Adrenomedullin (ADM) is a key regulator of endothelial barrier function and
vascular tone. Dipeptidyl peptidase 3 (DPP3) is a protease involved in the degradation of …

Background and Objectives: the cardiovascular adverse events including mortality and heart
failure, persist significantly during the first months after the acute phase of ST-segment …

Background This study assessed the ability of mid-regional proadrenomedullin (MR-
proADM) in comparison to conventional biomarkers (procalcitonin (PCT), lactate, C-reactive …

Objective To assess the cardiovascular prognostic value of mid-regional pro-
adrenomedullin (MR-proADM) and compare this with B-type natriuretic peptide (BNP) and N …

Early identification and diagnosis of sepsis and septic shock is vitally important; despite
appropriate management, mortality and morbidity rates remain high. For this reason, many …